These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 3925727)

  • 41. Four definitions of endogenous depression and the dexamethasone suppression test.
    Zimmerman M; Coryell W; Pfohl B; Stangl D
    J Affect Disord; 1985; 8(1):37-45. PubMed ID: 3156910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroendocrine and neurochemical measurements in depression.
    Davis KL; Hollister LE; Mathé AA; Davis BM; Rothpearl AB; Faull KF; Hsieh JY; Barchas JD; Berger PA
    Am J Psychiatry; 1981 Dec; 138(12):1555-62. PubMed ID: 6171169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M; De Ruyter M; Suy E
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroendocrine tests in depressive stroke patients.
    Dam H; Pedersen HE; Dige-Petersen H; Ahlgren P
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):1005-13. PubMed ID: 7824755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. More on the DST and the TRH test in adolescent depressions.
    Chabrol H; Claverie J
    Am J Psychiatry; 1983 Jul; 140(7):954. PubMed ID: 6407344
    [No Abstract]   [Full Text] [Related]  

  • 47. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE; Bender W; Mayr H; Niederschweiberer A; Schmauss M
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specificity of the combined dexamethasone suppression and TRH/TSH tests in melancholia.
    Steiner M; Goldman SE; Gupta RN; Boiago IM; Pellettier JR
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):655-9. PubMed ID: 3937177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRH stimulation test and depression.
    Peabody CA; Whiteford HA; Warner MD; Faull KF; Barchas JD; Berger PA
    Psychiatry Res; 1987 Sep; 22(1):21-8. PubMed ID: 2443941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dexamethasone suppression test: a biologic marker of endogenous depression?].
    Berger M; Klein HE
    Eur Arch Psychiatry Neurol Sci; 1984; 234(2):137-46. PubMed ID: 6499881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders.
    Agren H; Wide L
    Acta Psychiatr Scand; 1986 May; 73(5):549-58. PubMed ID: 3092581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroendocrine challenge studies in puerperal psychoses. Dexamethasone suppression and TRH stimulation.
    Paykel ES; del Campo AM; White W; Horton R
    Br J Psychiatry; 1991 Aug; 159():262-6. PubMed ID: 1773243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment.
    Dratcu L; Calil HM
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):99-117. PubMed ID: 2748868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive methylphenidate response and blunted thyrotropin-releasing hormone response in depression.
    Schwarcz G; Halaris A; Gwirtsman H; Ahles S
    Am J Psychiatry; 1986 Mar; 143(3):397. PubMed ID: 3082222
    [No Abstract]   [Full Text] [Related]  

  • 57. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder.
    Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S
    Rev Esp Fisiol; 1989; 45 Suppl():279-87. PubMed ID: 2518335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients.
    Shrimankar J; Soni SD; Sampath G
    Acta Psychiatr Scand; 1988 Jun; 77(6):712-8. PubMed ID: 3407439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.